術後の吐き気と嘔吐(PONV)の世界市場:メーカー別、地域別、種類別、用途別、市場予測(~2023)

【英語タイトル】Global Post-operative Nausea and Vomiting (PONV) Market 2018 by Manufacturers, Countries, Type and Application, Forecast to 2023

GlobalInfoResearchが出版した調査資料(GIR8105357)・商品コード:GIR8105357
・発行会社(調査会社):GlobalInfoResearch
・発行日:2018年8月31日
・ページ数:134
・レポート言語:英語
・レポート形式:PDF
・納品方法:Eメール
・調査対象地域:世界
・産業分野:医療・バイオ
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD3,480 ⇒換算¥375,840見積依頼/購入/質問フォーム
Multi User(10名様閲覧用)USD5,220 ⇒換算¥563,760見積依頼/購入/質問フォーム
Corporate User(同一法人内共有可)USD6,960 ⇒換算¥751,680見積依頼/購入/質問フォーム
販売価格オプションの説明
※お支払金額:換算金額(日本円)+消費税
※納期:即日〜2営業日(3日以上かかる場合は別途表記又はご連絡)
※お支払方法:納品日+5日以内に請求書を発行・郵送(請求書発行日より2ヶ月以内に銀行振込、振込先:三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能)
本調査レポートは、術後の吐き気と嘔吐(PONV)の世界市場について調べ、まとめました。種類別セグメントは、セロトニン拮抗薬、ステロイド、ドーパミン拮抗薬、NK-1受容体拮抗薬、その他等、用途別セグメントは、病院薬局、オンライン薬局、小売薬局およびドラッグストア等に区分しました。術後の吐き気と嘔吐(PONV)の世界市場概観、メーカー動向、メーカー別術後の吐き気と嘔吐(PONV)シェア、市場規模推移、市場規模予測、主要地域分析(北米、ヨーロッパ、アジア等)、主要国分析(日本、中国、アメリカ等)データなどの情報が含まれています。
・術後の吐き気と嘔吐(PONV)の市場概観
・術後の吐き気と嘔吐(PONV)のメーカー概要(事業概要、製品種類、価格、売上、市場シェア等)
・術後の吐き気と嘔吐(PONV)のメーカー別販売動向、市場シェア、市場集中度、競争動向
・術後の吐き気と嘔吐(PONV)の世界市場規模
・術後の吐き気と嘔吐(PONV)の北米市場分析(アメリカ、カナダ、メキシコ等)
・術後の吐き気と嘔吐(PONV)のアメリカ市場規模推移
・術後の吐き気と嘔吐(PONV)のカナダ市場規模推移
・術後の吐き気と嘔吐(PONV)のメキシコ市場規模推移
・術後の吐き気と嘔吐(PONV)のヨーロッパ市場分析(ドイツ、イギリス、ロシア、フランス、イタリア等)
・術後の吐き気と嘔吐(PONV)のドイツ市場規模推移
・術後の吐き気と嘔吐(PONV)のイギリス市場規模推移
・術後の吐き気と嘔吐(PONV)のロシア市場規模推移
・術後の吐き気と嘔吐(PONV)のアジア市場分析(日本、中国、韓国、インド、東南アジア等)
・術後の吐き気と嘔吐(PONV)の日本市場規模推移
・術後の吐き気と嘔吐(PONV)の中国市場規模推移
・術後の吐き気と嘔吐(PONV)の韓国市場規模推移
・術後の吐き気と嘔吐(PONV)のインド市場規模推移
・術後の吐き気と嘔吐(PONV)の東南アジア市場規模推移
・術後の吐き気と嘔吐(PONV)の南米市場分析(ブラジル、アルゼンチン等)
・術後の吐き気と嘔吐(PONV)の中東・アフリカ市場分析(サウジアラビア、UAE、南アフリカ等)
・術後の吐き気と嘔吐(PONV)の種類別分析/市場規模推移(セロトニン拮抗薬、ステロイド、ドーパミン拮抗薬、NK-1受容体拮抗薬、その他)
・術後の吐き気と嘔吐(PONV)の用途別分析/市場規模推移(病院薬局、オンライン薬局、小売薬局およびドラッグストア)
・術後の吐き気と嘔吐(PONV)の市場予測(地域別予測、種類別予測、用途別予測)
・術後の吐き気と嘔吐(PONV)の販売チャネル・代理店・貿易業者・ディーラー分析
【レポートの概要】

PONV in adults include serotonin antagonists; such as, ramosetron, granisetron, palonosetron, ondansetron, dolasetron, and tropisetron, neurokinin-1 (NK-1) receptor antagonists; such as aprepitant, and rolapitant, steroids; such as dexamethasone and methylprednisolone, dopamine antagonists as transdermal scopolamine [TDS] and others; such as butyrophenones as well as antihistamines (dimenhydrinate and meclizine). Postoperative nausea and vomiting is considered a major clinical issue that can diminish a patient’s quality of life

Scope of the Report:

This report studies the Post-operative Nausea and Vomiting (PONV) market status and outlook of Global and major regions, from angles of players, countries, product types and end industries; this report analyzes the top players in global market, and splits the Post-operative Nausea and Vomiting (PONV) market by product type and applications/end industries.

Major factors boosting the growth of the post-operative nausea and vomiting market include large number of surgeries performed and rise in the rate of postoperative complications, such as, dizziness, vomiting, and nausea. However, strict regulatory approvals and high health care expenditure are predicted to hamper the growth of the PONV market during the forecast period.

The global Post-operative Nausea and Vomiting (PONV) market is valued at xx million USD in 2017 and is expected to reach xx million USD by the end of 2023, growing at a CAGR of xx% between 2017 and 2023.

The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions.

North America, especially The United States, will still play an important role which cannot be ignored. Any changes from United States might affect the development trend of Post-operative Nausea and Vomiting (PONV).

Europe also play important roles in global market, with market size of xx million USD in 2017 and will be xx million USD in 2023, with a CAGR of xx%.

Market Segment by Companies, this report covers

Acacia Pharma

Roche AG

Novartis

Ani Pharmaceuticals

Camurus

Sanofi

Helsinn Holding

Eisai Corporation

Merck

GlaxoSmithKline

Market Segment by Regions, regional analysis covers

North America (United States, Canada and Mexico)

Europe (Germany, France, UK, Russia and Italy)

Asia-Pacific (China, Japan, Korea, India and Southeast Asia)

South America (Brazil, Argentina, Colombia)

Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Market Segment by Type, covers

Serotonin Antagonists

Steroids

Dopamine Antagonists

NK-1 Receptor Antagonists

Others

Non-pharmacologic Treatment

Market Segment by Applications, can be divided into

Hospital Pharmacies

Online Pharmacies

Retail Pharmacies and Drug Stores

【レポートの目次】

Table of Contents

1 Post-operative Nausea and Vomiting (PONV) Market Overview

1.1 Product Overview and Scope of Post-operative Nausea and Vomiting (PONV)

1.2 Classification of Post-operative Nausea and Vomiting (PONV) by Types

1.2.1 Global Post-operative Nausea and Vomiting (PONV) Revenue Comparison by Types (2017-2023)

1.2.2 Global Post-operative Nausea and Vomiting (PONV) Revenue Market Share by Types in 2017

1.2.3 Serotonin Antagonists

1.2.4 Steroids

1.2.5 Dopamine Antagonists

1.2.6 NK-1 Receptor Antagonists

1.2.7 Others

1.2.8 Non-pharmacologic Treatment

1.3 Global Post-operative Nausea and Vomiting (PONV) Market by Application

1.3.1 Global Post-operative Nausea and Vomiting (PONV) Market Size and Market Share Comparison by Applications (2013-2023)

1.3.2 Hospital Pharmacies

1.3.3 Online Pharmacies

1.3.4 Retail Pharmacies and Drug Stores

1.4 Global Post-operative Nausea and Vomiting (PONV) Market by Regions

1.4.1 Global Post-operative Nausea and Vomiting (PONV) Market Size (Million USD) Comparison by Regions (2013-2023)

1.4.1 North America (USA, Canada and Mexico) Post-operative Nausea and Vomiting (PONV) Status and Prospect (2013-2023)

1.4.2 Europe (Germany, France, UK, Russia and Italy) Post-operative Nausea and Vomiting (PONV) Status and Prospect (2013-2023)

1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Post-operative Nausea and Vomiting (PONV) Status and Prospect (2013-2023)

1.4.4 South America (Brazil, Argentina, Colombia) Post-operative Nausea and Vomiting (PONV) Status and Prospect (2013-2023)

1.4.5 Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Post-operative Nausea and Vomiting (PONV) Status and Prospect (2013-2023)

1.5 Global Market Size of Post-operative Nausea and Vomiting (PONV) (2013-2023)

2 Manufacturers Profiles

2.1 Acacia Pharma

2.1.1 Business Overview

2.1.2 Post-operative Nausea and Vomiting (PONV) Type and Applications

2.1.2.1 Product A

2.1.2.2 Product B

2.1.3 Acacia Pharma Post-operative Nausea and Vomiting (PONV) Revenue, Gross Margin and Market Share (2016-2017)

2.2 Roche AG

2.2.1 Business Overview

2.2.2 Post-operative Nausea and Vomiting (PONV) Type and Applications

2.2.2.1 Product A

2.2.2.2 Product B

2.2.3 Roche AG Post-operative Nausea and Vomiting (PONV) Revenue, Gross Margin and Market Share (2016-2017)

2.3 Novartis

2.3.1 Business Overview

2.3.2 Post-operative Nausea and Vomiting (PONV) Type and Applications

2.3.2.1 Product A

2.3.2.2 Product B

2.3.3 Novartis Post-operative Nausea and Vomiting (PONV) Revenue, Gross Margin and Market Share (2016-2017)

2.4 Ani Pharmaceuticals

2.4.1 Business Overview

2.4.2 Post-operative Nausea and Vomiting (PONV) Type and Applications

2.4.2.1 Product A

2.4.2.2 Product B

2.4.3 Ani Pharmaceuticals Post-operative Nausea and Vomiting (PONV) Revenue, Gross Margin and Market Share (2016-2017)

2.5 Camurus

2.5.1 Business Overview

2.5.2 Post-operative Nausea and Vomiting (PONV) Type and Applications

2.5.2.1 Product A

2.5.2.2 Product B

2.5.3 Camurus Post-operative Nausea and Vomiting (PONV) Revenue, Gross Margin and Market Share (2016-2017)

2.6 Sanofi

2.6.1 Business Overview

2.6.2 Post-operative Nausea and Vomiting (PONV) Type and Applications

2.6.2.1 Product A

2.6.2.2 Product B

2.6.3 Sanofi Post-operative Nausea and Vomiting (PONV) Revenue, Gross Margin and Market Share (2016-2017)

2.7 Helsinn Holding

2.7.1 Business Overview

2.7.2 Post-operative Nausea and Vomiting (PONV) Type and Applications

2.7.2.1 Product A

2.7.2.2 Product B

2.7.3 Helsinn Holding Post-operative Nausea and Vomiting (PONV) Revenue, Gross Margin and Market Share (2016-2017)

2.8 Eisai Corporation

2.8.1 Business Overview

2.8.2 Post-operative Nausea and Vomiting (PONV) Type and Applications

2.8.2.1 Product A

2.8.2.2 Product B

2.8.3 Eisai Corporation Post-operative Nausea and Vomiting (PONV) Revenue, Gross Margin and Market Share (2016-2017)

2.9 Merck

2.9.1 Business Overview

2.9.2 Post-operative Nausea and Vomiting (PONV) Type and Applications

2.9.2.1 Product A

2.9.2.2 Product B

2.9.3 Merck Post-operative Nausea and Vomiting (PONV) Revenue, Gross Margin and Market Share (2016-2017)

2.10 GlaxoSmithKline

2.10.1 Business Overview

2.10.2 Post-operative Nausea and Vomiting (PONV) Type and Applications

2.10.2.1 Product A

2.10.2.2 Product B

2.10.3 GlaxoSmithKline Post-operative Nausea and Vomiting (PONV) Revenue, Gross Margin and Market Share (2016-2017)

3 Global Post-operative Nausea and Vomiting (PONV) Market Competition, by Players

3.1 Global Post-operative Nausea and Vomiting (PONV) Revenue and Share by Players (2013-2018)

3.2 Market Concentration Rate

3.2.1 Top 5 Post-operative Nausea and Vomiting (PONV) Players Market Share

3.2.2 Top 10 Post-operative Nausea and Vomiting (PONV) Players Market Share

3.3 Market Competition Trend

4 Global Post-operative Nausea and Vomiting (PONV) Market Size by Regions

4.1 Global Post-operative Nausea and Vomiting (PONV) Revenue and Market Share by Regions

4.2 North America Post-operative Nausea and Vomiting (PONV) Revenue and Growth Rate (2013-2018)

4.3 Europe Post-operative Nausea and Vomiting (PONV) Revenue and Growth Rate (2013-2018)

4.4 Asia-Pacific Post-operative Nausea and Vomiting (PONV) Revenue and Growth Rate (2013-2018)

4.5 South America Post-operative Nausea and Vomiting (PONV) Revenue and Growth Rate (2013-2018)

4.6 Middle East and Africa Post-operative Nausea and Vomiting (PONV) Revenue and Growth Rate (2013-2018)

5 North America Post-operative Nausea and Vomiting (PONV) Revenue by Countries

5.1 North America Post-operative Nausea and Vomiting (PONV) Revenue by Countries (2013-2018)

5.2 USA Post-operative Nausea and Vomiting (PONV) Revenue and Growth Rate (2013-2018)

5.3 Canada Post-operative Nausea and Vomiting (PONV) Revenue and Growth Rate (2013-2018)

5.4 Mexico Post-operative Nausea and Vomiting (PONV) Revenue and Growth Rate (2013-2018)

6 Europe Post-operative Nausea and Vomiting (PONV) Revenue by Countries

6.1 Europe Post-operative Nausea and Vomiting (PONV) Revenue by Countries (2013-2018)

6.2 Germany Post-operative Nausea and Vomiting (PONV) Revenue and Growth Rate (2013-2018)

6.3 UK Post-operative Nausea and Vomiting (PONV) Revenue and Growth Rate (2013-2018)

6.4 France Post-operative Nausea and Vomiting (PONV) Revenue and Growth Rate (2013-2018)

6.5 Russia Post-operative Nausea and Vomiting (PONV) Revenue and Growth Rate (2013-2018)

6.6 Italy Post-operative Nausea and Vomiting (PONV) Revenue and Growth Rate (2013-2018)

7 Asia-Pacific Post-operative Nausea and Vomiting (PONV) Revenue by Countries

7.1 Asia-Pacific Post-operative Nausea and Vomiting (PONV) Revenue by Countries (2013-2018)

7.2 China Post-operative Nausea and Vomiting (PONV) Revenue and Growth Rate (2013-2018)

7.3 Japan Post-operative Nausea and Vomiting (PONV) Revenue and Growth Rate (2013-2018)

7.4 Korea Post-operative Nausea and Vomiting (PONV) Revenue and Growth Rate (2013-2018)

7.5 India Post-operative Nausea and Vomiting (PONV) Revenue and Growth Rate (2013-2018)

7.6 Southeast Asia Post-operative Nausea and Vomiting (PONV) Revenue and Growth Rate (2013-2018)

8 South America Post-operative Nausea and Vomiting (PONV) Revenue by Countries

8.1 South America Post-operative Nausea and Vomiting (PONV) Revenue by Countries (2013-2018)

8.2 Brazil Post-operative Nausea and Vomiting (PONV) Revenue and Growth Rate (2013-2018)

8.3 Argentina Post-operative Nausea and Vomiting (PONV) Revenue and Growth Rate (2013-2018)

8.4 Colombia Post-operative Nausea and Vomiting (PONV) Revenue and Growth Rate (2013-2018)

9 Middle East and Africa Revenue Post-operative Nausea and Vomiting (PONV) by Countries

9.1 Middle East and Africa Post-operative Nausea and Vomiting (PONV) Revenue by Countries (2013-2018)

9.2 Saudi Arabia Post-operative Nausea and Vomiting (PONV) Revenue and Growth Rate (2013-2018)

9.3 UAE Post-operative Nausea and Vomiting (PONV) Revenue and Growth Rate (2013-2018)

9.4 Egypt Post-operative Nausea and Vomiting (PONV) Revenue and Growth Rate (2013-2018)

9.5 Nigeria Post-operative Nausea and Vomiting (PONV) Revenue and Growth Rate (2013-2018)

9.6 South Africa Post-operative Nausea and Vomiting (PONV) Revenue and Growth Rate (2013-2018)

10 Global Post-operative Nausea and Vomiting (PONV) Market Segment by Type

10.1 Global Post-operative Nausea and Vomiting (PONV) Revenue and Market Share by Type (2013-2018)

10.2 Global Post-operative Nausea and Vomiting (PONV) Market Forecast by Type (2018-2023)

10.3 Serotonin Antagonists Revenue Growth Rate (2013-2023)

10.4 Steroids Revenue Growth Rate (2013-2023)

10.5 Dopamine Antagonists Revenue Growth Rate (2013-2023)

10.6 NK-1 Receptor Antagonists Revenue Growth Rate (2013-2023)

10.7 Others Revenue Growth Rate (2013-2023)

10.8 Non-pharmacologic Treatment Revenue Growth Rate (2013-2023)

11 Global Post-operative Nausea and Vomiting (PONV) Market Segment by Application

11.1 Global Post-operative Nausea and Vomiting (PONV) Revenue Market Share by Application (2013-2018)

11.2 Post-operative Nausea and Vomiting (PONV) Market Forecast by Application (2018-2023)

11.3 Hospital Pharmacies Revenue Growth (2013-2018)

11.4 Online Pharmacies Revenue Growth (2013-2018)

11.5 Retail Pharmacies and Drug Stores Revenue Growth (2013-2018)

12 Global Post-operative Nausea and Vomiting (PONV) Market Size Forecast (2018-2023)

12.1 Global Post-operative Nausea and Vomiting (PONV) Market Size Forecast (2018-2023)

12.2 Global Post-operative Nausea and Vomiting (PONV) Market Forecast by Regions (2018-2023)

12.3 North America Post-operative Nausea and Vomiting (PONV) Revenue Market Forecast (2018-2023)

12.4 Europe Post-operative Nausea and Vomiting (PONV) Revenue Market Forecast (2018-2023)

12.5 Asia-Pacific Post-operative Nausea and Vomiting (PONV) Revenue Market Forecast (2018-2023)

12.6 South America Post-operative Nausea and Vomiting (PONV) Revenue Market Forecast (2018-2023)

12.7 Middle East and Africa Post-operative Nausea and Vomiting (PONV) Revenue Market Forecast (2018-2023)

13 Research Findings and Conclusion

14 Appendix

14.1 Methodology

14.2 Data Source

List of Tables and Figures



Figure Post-operative Nausea and Vomiting (PONV) Picture

Table Product Specifications of Post-operative Nausea and Vomiting (PONV)

Table Global Post-operative Nausea and Vomiting (PONV) and Revenue (Million USD) Market Split by Product Type

Figure Global Post-operative Nausea and Vomiting (PONV) Revenue Market Share by Types in 2017

Figure Serotonin Antagonists Picture

Figure Steroids Picture

Figure Dopamine Antagonists Picture

Figure NK-1 Receptor Antagonists Picture

Figure Others Picture

Figure Non-pharmacologic Treatment Picture

Table Global Post-operative Nausea and Vomiting (PONV) Revenue (Million USD) by Application (2013-2023)

Figure Post-operative Nausea and Vomiting (PONV) Revenue Market Share by Applications in 2017

Figure Hospital Pharmacies Picture

Figure Online Pharmacies Picture

Figure Retail Pharmacies and Drug Stores Picture

Table Global Market Post-operative Nausea and Vomiting (PONV) Revenue (Million USD) Comparison by Regions 2013-2023

Figure North America Post-operative Nausea and Vomiting (PONV) Revenue (Million USD) and Growth Rate (2013-2023)

Figure Europe Post-operative Nausea and Vomiting (PONV) Revenue (Million USD) and Growth Rate (2013-2023)

Figure Asia-Pacific Post-operative Nausea and Vomiting (PONV) Revenue (Million USD) and Growth Rate (2013-2023)

Figure South America Post-operative Nausea and Vomiting (PONV) Revenue (Million USD) and Growth Rate (2013-2023)

Figure Middle East and Africa Post-operative Nausea and Vomiting (PONV) Revenue (Million USD) and Growth Rate (2013-2023)

Figure Global Post-operative Nausea and Vomiting (PONV) Revenue (Million USD) and Growth Rate (2013-2023)

Table Acacia Pharma Basic Information, Manufacturing Base and Competitors

Table Acacia Pharma Post-operative Nausea and Vomiting (PONV) Type and Applications

Table Acacia Pharma Post-operative Nausea and Vomiting (PONV) Revenue, Gross Margin and Market Share (2016-2017)

Table Roche AG Basic Information, Manufacturing Base and Competitors

Table Roche AG Post-operative Nausea and Vomiting (PONV) Type and Applications

Table Roche AG Post-operative Nausea and Vomiting (PONV) Revenue, Gross Margin and Market Share (2016-2017)

Table Novartis Basic Information, Manufacturing Base and Competitors

Table Novartis Post-operative Nausea and Vomiting (PONV) Type and Applications

Table Novartis Post-operative Nausea and Vomiting (PONV) Revenue, Gross Margin and Market Share (2016-2017)

Table Ani Pharmaceuticals Basic Information, Manufacturing Base and Competitors

Table Ani Pharmaceuticals Post-operative Nausea and Vomiting (PONV) Type and Applications

Table Ani Pharmaceuticals Post-operative Nausea and Vomiting (PONV) Revenue, Gross Margin and Market Share (2016-2017)

Table Camurus Basic Information, Manufacturing Base and Competitors

Table Camurus Post-operative Nausea and Vomiting (PONV) Type and Applications

Table Camurus Post-operative Nausea and Vomiting (PONV) Revenue, Gross Margin and Market Share (2016-2017)

Table Sanofi Basic Information, Manufacturing Base and Competitors

Table Sanofi Post-operative Nausea and Vomiting (PONV) Type and Applications

Table Sanofi Post-operative Nausea and Vomiting (PONV) Revenue, Gross Margin and Market Share (2016-2017)

Table Helsinn Holding Basic Information, Manufacturing Base and Competitors

Table Helsinn Holding Post-operative Nausea and Vomiting (PONV) Type and Applications

Table Helsinn Holding Post-operative Nausea and Vomiting (PONV) Revenue, Gross Margin and Market Share (2016-2017)

Table Eisai Corporation Basic Information, Manufacturing Base and Competitors

Table Eisai Corporation Post-operative Nausea and Vomiting (PONV) Type and Applications

Table Eisai Corporation Post-operative Nausea and Vomiting (PONV) Revenue, Gross Margin and Market Share (2016-2017)

Table Merck Basic Information, Manufacturing Base and Competitors

Table Merck Post-operative Nausea and Vomiting (PONV) Type and Applications

Table Merck Post-operative Nausea and Vomiting (PONV) Revenue, Gross Margin and Market Share (2016-2017)

Table GlaxoSmithKline Basic Information, Manufacturing Base and Competitors

Table GlaxoSmithKline Post-operative Nausea and Vomiting (PONV) Type and Applications

Table GlaxoSmithKline Post-operative Nausea and Vomiting (PONV) Revenue, Gross Margin and Market Share (2016-2017)

Table Global Post-operative Nausea and Vomiting (PONV) Revenue (Million USD) by Players (2013-2018)

Table Global Post-operative Nausea and Vomiting (PONV) Revenue Share by Players (2013-2018)

Figure Global Post-operative Nausea and Vomiting (PONV) Revenue Share by Players in 2016

Figure Global Post-operative Nausea and Vomiting (PONV) Revenue Share by Players in 2017

Figure Global Top 5 Players Post-operative Nausea and Vomiting (PONV) Revenue Market Share in 2017

Figure Global Top 10 Players Post-operative Nausea and Vomiting (PONV) Revenue Market Share in 2017

Figure Global Post-operative Nausea and Vomiting (PONV) Revenue (Million USD) and Growth Rate (%) (2013-2018)

Table Global Post-operative Nausea and Vomiting (PONV) Revenue (Million USD) by Regions (2013-2018)

Table Global Post-operative Nausea and Vomiting (PONV) Revenue Market Share by Regions (2013-2018)

Figure Global Post-operative Nausea and Vomiting (PONV) Revenue Market Share by Regions (2013-2018)

Figure Global Post-operative Nausea and Vomiting (PONV) Revenue Market Share by Regions in 2017

Figure North America Post-operative Nausea and Vomiting (PONV) Revenue and Growth Rate (2013-2018)

Figure Europe Post-operative Nausea and Vomiting (PONV) Revenue and Growth Rate (2013-2018)

Figure Asia-Pacific Post-operative Nausea and Vomiting (PONV) Revenue and Growth Rate (2013-2018)

Figure South America Post-operative Nausea and Vomiting (PONV) Revenue and Growth Rate (2013-2018)

Figure Middle East and Africa Post-operative Nausea and Vomiting (PONV) Revenue and Growth Rate (2013-2018)

Table North America Post-operative Nausea and Vomiting (PONV) Revenue by Countries (2013-2018)

Table North America Post-operative Nausea and Vomiting (PONV) Revenue Market Share by Countries (2013-2018)

Figure North America Post-operative Nausea and Vomiting (PONV) Revenue Market Share by Countries (2013-2018)

Figure North America Post-operative Nausea and Vomiting (PONV) Revenue Market Share by Countries in 2017

Figure USA Post-operative Nausea and Vomiting (PONV) Revenue and Growth Rate (2013-2018)

Figure Canada Post-operative Nausea and Vomiting (PONV) Revenue and Growth Rate (2013-2018)

Figure Mexico Post-operative Nausea and Vomiting (PONV) Revenue and Growth Rate (2013-2018)

Table Europe Post-operative Nausea and Vomiting (PONV) Revenue (Million USD) by Countries (2013-2018)

Figure Europe Post-operative Nausea and Vomiting (PONV) Revenue Market Share by Countries (2013-2018)

Figure Europe Post-operative Nausea and Vomiting (PONV) Revenue Market Share by Countries in 2017

Figure Germany Post-operative Nausea and Vomiting (PONV) Revenue and Growth Rate (2013-2018)

Figure UK Post-operative Nausea and Vomiting (PONV) Revenue and Growth Rate (2013-2018)

Figure France Post-operative Nausea and Vomiting (PONV) Revenue and Growth Rate (2013-2018)

Figure Russia Post-operative Nausea and Vomiting (PONV) Revenue and Growth Rate (2013-2018)

Figure Italy Post-operative Nausea and Vomiting (PONV) Revenue and Growth Rate (2013-2018)

Table Asia-Pacific Post-operative Nausea and Vomiting (PONV) Revenue (Million USD) by Countries (2013-2018)

Figure Asia-Pacific Post-operative Nausea and Vomiting (PONV) Revenue Market Share by Countries (2013-2018)

Figure Asia-Pacific Post-operative Nausea and Vomiting (PONV) Revenue Market Share by Countries in 2017

Figure China Post-operative Nausea and Vomiting (PONV) Revenue and Growth Rate (2013-2018)

Figure Japan Post-operative Nausea and Vomiting (PONV) Revenue and Growth Rate (2013-2018)

Figure Korea Post-operative Nausea and Vomiting (PONV) Revenue and Growth Rate (2013-2018)

Figure India Post-operative Nausea and Vomiting (PONV) Revenue and Growth Rate (2013-2018)

Figure Southeast Asia Post-operative Nausea and Vomiting (PONV) Revenue and Growth Rate (2013-2018)

Table South America Post-operative Nausea and Vomiting (PONV) Revenue by Countries (2013-2018)

Table South America Post-operative Nausea and Vomiting (PONV) Revenue Market Share by Countries (2013-2018)

Figure South America Post-operative Nausea and Vomiting (PONV) Revenue Market Share by Countries (2013-2018)

Figure South America Post-operative Nausea and Vomiting (PONV) Revenue Market Share by Countries in 2017

Figure Brazil Post-operative Nausea and Vomiting (PONV) Revenue and Growth Rate (2013-2018)

Figure Argentina Post-operative Nausea and Vomiting (PONV) Revenue and Growth Rate (2013-2018)

Figure Colombia Post-operative Nausea and Vomiting (PONV) Revenue and Growth Rate (2013-2018)

Table Middle East and Africa Post-operative Nausea and Vomiting (PONV) Revenue (Million USD) by Countries (2013-2018)

Table Middle East and Africa Post-operative Nausea and Vomiting (PONV) Revenue Market Share by Countries (2013-2018)

Figure Middle East and Africa Post-operative Nausea and Vomiting (PONV) Revenue Market Share by Countries (2013-2018)

Figure Middle East and Africa Post-operative Nausea and Vomiting (PONV) Revenue Market Share by Countries in 2017

Figure Saudi Arabia Post-operative Nausea and Vomiting (PONV) Revenue and Growth Rate (2013-2018)

Figure UAE Post-operative Nausea and Vomiting (PONV) Revenue and Growth Rate (2013-2018)

Figure Egypt Post-operative Nausea and Vomiting (PONV) Revenue and Growth Rate (2013-2018)

Figure Nigeria Post-operative Nausea and Vomiting (PONV) Revenue and Growth Rate (2013-2018)

Figure South Africa Post-operative Nausea and Vomiting (PONV) Revenue and Growth Rate (2013-2018)

Table Global Post-operative Nausea and Vomiting (PONV) Revenue (Million USD) by Type (2013-2018)

Table Global Post-operative Nausea and Vomiting (PONV) Revenue Share by Type (2013-2018)

Figure Global Post-operative Nausea and Vomiting (PONV) Revenue Share by Type (2013-2018)

Figure Global Post-operative Nausea and Vomiting (PONV) Revenue Share by Type in 2017

Table Global Post-operative Nausea and Vomiting (PONV) Revenue Forecast by Type (2018-2023)

Figure Global Post-operative Nausea and Vomiting (PONV) Market Share Forecast by Type (2018-2023)

Figure Global Serotonin Antagonists Revenue Growth Rate (2013-2018)

Figure Global Steroids Revenue Growth Rate (2013-2018)

Figure Global Dopamine Antagonists Revenue Growth Rate (2013-2018)

Figure Global NK-1 Receptor Antagonists Revenue Growth Rate (2013-2018)

Figure Global Others Revenue Growth Rate (2013-2018)

Figure Global Non-pharmacologic Treatment Revenue Growth Rate (2013-2018)

Table Global Post-operative Nausea and Vomiting (PONV) Revenue by Application (2013-2018)

Table Global Post-operative Nausea and Vomiting (PONV) Revenue Share by Application (2013-2018)

Figure Global Post-operative Nausea and Vomiting (PONV) Revenue Share by Application (2013-2018)

Figure Global Post-operative Nausea and Vomiting (PONV) Revenue Share by Application in 2017

Table Global Post-operative Nausea and Vomiting (PONV) Revenue Forecast by Application (2018-2023)

Figure Global Post-operative Nausea and Vomiting (PONV) Market Share Forecast by Application (2018-2023)

Figure Global Hospital Pharmacies Revenue Growth Rate (2013-2018)

Figure Global Online Pharmacies Revenue Growth Rate (2013-2018)

Figure Global Retail Pharmacies and Drug Stores Revenue Growth Rate (2013-2018)

Figure Global Post-operative Nausea and Vomiting (PONV) Revenue (Million USD) and Growth Rate Forecast (2018 -2023)

Table Global Post-operative Nausea and Vomiting (PONV) Revenue (Million USD) Forecast by Regions (2018-2023)

Figure Global Post-operative Nausea and Vomiting (PONV) Revenue Market Share Forecast by Regions (2018-2023)

Figure North America Post-operative Nausea and Vomiting (PONV) Revenue Market Forecast (2018-2023)

Figure Europe Post-operative Nausea and Vomiting (PONV) Revenue Market Forecast (2018-2023)

Figure Asia-Pacific Post-operative Nausea and Vomiting (PONV) Revenue Market Forecast (2018-2023)

Figure South America Post-operative Nausea and Vomiting (PONV) Revenue Market Forecast (2018-2023)

Figure Middle East and Africa Post-operative Nausea and Vomiting (PONV) Revenue Market Forecast (2018-2023)



【レポートのキーワード】

術後の吐き気と嘔吐(PONV)、セロトニン拮抗薬、ステロイド、ドーパミン拮抗薬、NK-1受容体拮抗薬、その他、病院薬局、オンライン薬局、小売薬局およびドラッグストア

★調査レポート[術後の吐き気と嘔吐(PONV)の世界市場:メーカー別、地域別、種類別、用途別、市場予測(~2023)] (コード:GIR8105357)販売に関する免責事項を必ずご確認ください。
★調査レポート[術後の吐き気と嘔吐(PONV)の世界市場:メーカー別、地域別、種類別、用途別、市場予測(~2023)]についてメールでお問い合わせ


◆H&Iグローバルリサーチのお客様(例)◆